Dosing & Titration Schedule The dosing schedule for Wegovy is carefully designed to help your body adjust to the medication while minimizing side effects
Zepbound received FDA approval for moderate-to-severe obstructive sleep apnea in adults with obesity in December 2024, and Wegovy gained a cardiovascular risk reduction indication for patients with established heart disease and obesity
Once bound to GLP-1 receptor (a 7-transmembrane protein that belongs to the class B1 G-protein-coupled receptor family) (180), GLP-1 RAs (as GLP-1) initiate a signaling cascade that activates adenylyl cyclase (AC), increasing cAMP levels (in a dose-dependent manner) which, in turn, interacts with several downstream molecules, such as mitogen-activated protein kinase (MAPK), protein kinase A (PKA) and PI3K (181, 182)
Meto's resources on metabolic syndrome and fatty liver disease provide relevant context for why VAT reduction translates to systemic metabolic benefit
Monitor blood ketone levels to confirm you are entering and maintaining nutritional ketosis